Search results
Showing 31 to 45 of 85 results for menopause
Women with premature ovarian insufficiency can experience the effects of menopause for most of their adult life. This can lead to...
The choice of surgery will also be affected by whether you have had your menopause or not, any previous surgery you may have had, and...
Evidence-based recommendations on relugolix–estradiol–norethisterone acetate (Ryeqo) for treating moderate to severe symptoms of uterine fibroids in adults of reproductive age.
Evidence-based recommendations on palbociclib (Ibrance) with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy.
symptoms. Source guidance details Comes from guidance Menopause: identification and management Number NG23 Date issued
treatment. Source guidance details Comes from guidance Menopause: identification and management Number NG23 Date issued
Although breast density decreases with age, and particularly after the menopause, there is no sudden change at any particular age. For...
Laparoscopic removal of uterine fibroids with power morcellation (IPG703)
Evidence-based recommendations on laparoscopic removal of uterine fibroids with power morcellation in adults. This involves cutting the fibroids into small pieces to remove them.
View recommendations for IPG703Show all sections
indicated. Source guidance details Comes from guidance Menopause: identification and management Number NG23 Date issued
Evidence-based recommendations on liposuction for chronic lipoedema in adults. This involves using suction to remove abnormal fat.
View recommendations for IPG721Show all sections
Early and locally advanced breast cancer: diagnosis and management (NG101)
This guideline covers diagnosing and managing early and locally advanced breast cancer. It aims to help healthcare professionals offer the right treatments to people, taking into account the person's individual preferences.
Evidence-based recommendations on pembrolizumab (Keytruda) with lenvatinib (Lenvima) for treating advanced or recurrent endometrial cancer in adults.
Relugolix–estradiol–norethisterone for treating symptoms of endometriosis (TA1057)
Evidence-based recommendations on relugolix–estradiol–norethisterone (Ryeqo) for treating symptoms of endometriosis in adults of reproductive age.
Show all sections
This guideline covers assessing and managing heavy menstrual bleeding (menorrhagia). It aims to help healthcare professionals investigate the cause of heavy periods that are affecting a woman’s quality of life and to offer the right treatments, taking into account the woman’s priorities and preferences.
This guideline covers diagnosing and managing endometriosis, including where fertility is a priority. It aims to raise awareness of endometriosis symptoms, and to provide clear advice on referral, diagnosis and the range of treatments available.